Association of Anemia and Iron Parameters With Mortality Among Patients Undergoing Prevalent Hemodialysis in Taiwan: The AIM‐HD Study

BACKGROUND: The Taiwan Health Insurance Bureau has conducted a bundled payment system for hemodialysis reimbursement since 1995. The maximum dose of erythropoiesis‐stimulating agents allowed by insurance is capped at 20 000 U of epoetin or 100 μg of darbepoetin alfa per month. Nephrologists have avo...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuo, Ko‐Lin, Hung, Szu‐Chun, Tseng, Wei‐Cheng, Tsai, Ming‐Tsun, Liu, Jia‐Sin, Lin, Ming‐Huang, Hsu, Chih‐Cheng, Tarng, Der‐Cherng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201445/
https://www.ncbi.nlm.nih.gov/pubmed/30371224
http://dx.doi.org/10.1161/JAHA.118.009206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201445/
https://www.ncbi.nlm.nih.gov/pubmed/30371224
http://dx.doi.org/10.1161/JAHA.118.009206

Ejemplares similares